IIT Madras Launches Cancer Genome Atlas
Analysis based on 14 articles · First reported Feb 03, 2026 · Last updated Feb 04, 2026
The launch of the Bharat Cancer Genome Atlas by IIT Madras, with significant funding from Hyundai Motor Company===Hyundai Motor India Foundation, is a positive development for the biotechnology and healthcare sectors in India. It is expected to foster advancements in cancer research, potentially leading to new diagnostic tools and treatments, which could attract further investment in the Indian medical research landscape.
The IIT Madras launched the Bharat Cancer Genome Atlas (BCGA), a pioneering database for paediatric leukaemia, colorectal, and pancreatic cancers, on World Cancer Day. This initiative, part of the broader Bharat Cancer Genome Grid (BCG2), aims to address the critical gap in genomic data for cancers prevalent in India, which has been under-represented in global studies. The project received substantial support of Rs 56 crore from the Hyundai Motor Company===Hyundai Motor India Foundation. The BCGA is designed to accelerate the adoption of Whole Genome Sequencing in oncology practice, facilitate early diagnosis, track disease progression, and guide therapeutic decisions. It is a collaborative effort involving institutions like Karkinos Healthcare, K. K. Child Trust Hospital, and Institute of Child Health, Chennai. The database is publicly accessible to researchers and clinicians globally, promising to enhance understanding of cancer's genetic basis and advance personalized medicine in India.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard